UniConnect

The company is integrating its newly purchased LIMS and genome interpretation and reporting capabilities to provide a single platform for cancer and inherited disease diagnostics.

According to Sunquest, UniConnect's technology will augment its own existing solutions for molecular diagnostics.

The deal provides Clinical Genomics with a "cornerstone piece" as it readies its blood-based test for colorectal cancer recurrence for commercialization in the US later this year.

Tute has partnered with LIMS provider UniConnect to build infrastructure to support gene panels for mitochondrial, metabolic, and other genetic diseases.

Tute will provide its cloud-based informatics and genome analysis platform to support two new NGS testing panels that NSO is developing.

NEW YORK (GenomeWeb) – UniConnect said this week that Children's Hospital Colorado's molecular diagnostics laboratory has deployed its Precision Molecular Diagnostics (PMDx) laboratory information system.

NEW YORK (GenomeWeb) — UniConnect last week unveiled PrecisionMDx, a specialized version of its flagship UniFlow laboratory process management software for molecular testing laboratories.

NEW YORK (GenomeWeb) – Utah-based software firm UniConnect said this week that it will donate UniFlow, its laboratory process management software, to George Washington University's Computational Biology Institute (CBI).

Selah Genomics has licensed UniFlow, UniConnect's laboratory information management system, to manage molecular and clinical data for its clinical diagnostic services business.

UniConnect said recently that Dupont Pioneer is using its UniFlow laboratory information management software system to support ongoing efforts to develop new plant products that have higher yields and are more resistant to pests and diseases.

Pages

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.